|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 88.12 USD | -1.73% |
|
+0.46% | -7.44% |
| 22/10 | BioNTech, Gilead to test drug combination in advanced breast cancer trial | RE |
| 22/10 | BioNTech, Gilead to Test Combination Treatment for Breast Cancer | MT |
| Market Cap | 1.98TCr 2.21TCr 1.83TCr 1.65TCr 3.1TCr 2,10100Cr 3.15TCr 22TCr 8.7TCr 1,10100Cr 8.31TCr 8.13TCr 3,47100Cr | P/E 2026 * |
-13.4x | P/E 2027 * | -14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 866.95Cr 970.83Cr 800.9Cr 725.79Cr 1.36TCr 92TCr 1.38TCr 9.64TCr 3.82TCr 48TCr 3.64TCr 3.57TCr 1,52200Cr | EV / Sales 2026 * |
4.88x | EV / Sales 2027 * | 5.57x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BNTX | Delayed | |
Tradegate
| 22UA | Real-time | |
|
CBOE
| BNTX | Real-time | |
|
Xetra
| 22UA | Delayed | |
|
Boerse Muenchen
| 22UA | Real-time | |
|
Börse Stuttgart
| 22UA | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 22UA | Delayed | |
|
Mexican S.E.
| BNTX N | End-of-day quote | |
|
CBOE
| 0A3M | Real-time | |
|
Berne S.E.
| 22UA | End-of-day quote | |
|
London S.E.
| 0A3M | Delayed | |
|
Wiener Boerse
| BNTX | End-of-day quote |
Last Transcript: BioNTech SE
| 1 day | -1.73% | ||
| 1 week | +0.46% | ||
| Current month | -10.36% | ||
| 1 month | -10.51% | ||
| 3 months | -4.29% | ||
| 6 months | -16.53% | ||
| Current year | -7.44% |
| 1 week | 87.52 |  | 92.73 |
| 1 month | 87.36 | | 100.21 |
| Current year | 79.52 | | 124 |
| 1 year | 79.52 | | 124 |
| 3 years | 76.53 | | 131.49 |
| 5 years | 76.53 | | 374.58 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 61 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 56 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/10/26 | Sell | Chief Executive Officer | -36,209 | 0.0150% | ||
| 07/10/26 | Sell | Chief Executive Officer | -24,000 | 0.0099% | ||
| 06/10/26 | Sell | Chief Executive Officer | -21,000 | 0.0087% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.73% | +0.46% | -15.88% | -4.76% | 2.21TCr | |
| +2.41% | +0.29% | +42.02% | +71.57% | 6.47TCr | |
| -0.15% | +7.50% | +11.01% | +73.48% | 5.48TCr | |
| +0.57% | +4.60% | +10.07% | +92.86% | 5.35TCr | |
| +0.37% | +4.67% | +27.03% | +52.07% | 4.6TCr | |
| -1.21% | +2.32% | +21.80% | +123.81% | 4.29TCr | |
| -0.37% | +5.07% | +249.91% | +918.74% | 4.01TCr | |
| +0.05% | +0.21% | +18.26% | +58.53% | 3.35TCr | |
| -0.38% | +5.68% | +36.43% | +27.54% | 2.37TCr | |
| +1.19% | -4.98% | +29.01% | -0.65% | 2.4TCr | |
| Average | +0.08% | +2.22% | +42.97% | +141.32% | 4.05TCr | |
| Weighted average by Cap. | +0.27% | +2.61% | +44.11% | +149.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 177.52Cr 198.79Cr 163.99Cr 148.61Cr 278.04Cr 19TCr 282.64Cr 1.97TCr 781.29Cr 9.89TCr 746.03Cr 730.16Cr 31TCr | 179.72Cr 201.25Cr 166.03Cr 150.46Cr 281.49Cr 19TCr 286.14Cr 2TCr 790.99Cr 10TCr 755.29Cr 739.23Cr 32TCr |
| Net income | -145.75Cr -163.22Cr -134.65Cr -122.02Cr -228.28Cr -15TCr -232.06Cr -1.62TCr -641.49Cr -8.12TCr -612.53Cr -599.51Cr -26TCr | -128.23Cr -143.59Cr -118.46Cr -107.35Cr -200.84Cr -14TCr -204.16Cr -1.43TCr -564.36Cr -7.14TCr -538.89Cr -527.43Cr -23TCr |
| Net Debt | -1.11TCr -1.24TCr -1.03TCr -929.01Cr -1.74TCr -1,18000Cr -1.77TCr -12TCr -4.88TCr -62TCr -4.66TCr -4.56TCr -1,94900Cr | -975.27Cr -1.09TCr -900.96Cr -816.48Cr -1.53TCr -1,03700Cr -1.55TCr -11TCr -4.29TCr -54TCr -4.1TCr -4.01TCr -1,71300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $88.12 | -1.73% | 8,38,703 |
| 22/26/22 | $89.67 | -1.77% | 11,64,496 |
| 21/26/21 | $91.29 | +0.13% | 11,13,487 |
| 20/26/20 | $91.17 | +2.20% | 18,36,228 |
| 19/26/19 | $89.21 | +1.71% | 13,43,030 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
